These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26184712)

  • 1. Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade.
    Blau JE; Abegg MR; Flegel WA; Zhao X; Harlan DM; Rother KI
    Am J Transplant; 2015 Nov; 15(11):2995-3001. PubMed ID: 26184712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up after clinical islet transplantation.
    Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
    Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR).
    CITR Research Group
    Cell Transplant; 2009; 18(7):753-67. PubMed ID: 19796497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
    Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.
    Hering BJ; Clarke WR; Bridges ND; Eggerman TL; Alejandro R; Bellin MD; Chaloner K; Czarniecki CW; Goldstein JS; Hunsicker LG; Kaufman DB; Korsgren O; Larsen CP; Luo X; Markmann JF; Naji A; Oberholzer J; Posselt AM; Rickels MR; Ricordi C; Robien MA; Senior PA; Shapiro AM; Stock PG; Turgeon NA;
    Diabetes Care; 2016 Jul; 39(7):1230-40. PubMed ID: 27208344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
    Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
    N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
    Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
    Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
    Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
    Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
    Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
    Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
    Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
    Hering BJ; Kandaswamy R; Ansite JD; Eckman PM; Nakano M; Sawada T; Matsumoto I; Ihm SH; Zhang HJ; Parkey J; Hunter DW; Sutherland DE
    JAMA; 2005 Feb; 293(7):830-5. PubMed ID: 15713772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.
    Rickels MR; Liu C; Shlansky-Goldberg RD; Soleimanpour SA; Vivek K; Kamoun M; Min Z; Markmann E; Palangian M; Dalton-Bakes C; Fuller C; Chiou AJ; Barker CF; Luning Prak ET; Naji A
    Diabetes; 2013 Aug; 62(8):2890-7. PubMed ID: 23630300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemia, Hypoglycemia, and Costs of Simultaneous Islet-Kidney or Islet After Kidney Transplantation Versus Intensive Insulin Therapy and Waiting List for Islet Transplantation.
    Gerber PA; Locher R; Zuellig RA; Tschopp O; Ajdler-Schaeffler E; Kron P; Oberkofler C; Brändle M; Spinas GA; Lehmann R
    Transplantation; 2015 Oct; 99(10):2174-80. PubMed ID: 25905979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.